BioTech Hostile Takeover: Biogen Plays For Facet
Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.'s (BIIB) letter dated September 4, 2009 offering $14.50 per share for all of the outstanding shares ...Read Full Story »










